//Natural cross immunity confirmed

Natural cross immunity confirmed

Download free high-res copies of my two text books and the new posters. Any donations using this link help the work of campbell teaching.
https://drjohncampbell.co.uk/

Massachusetts will give you a $75 gift card if you get vaccinated or boosted

https://www.msn.com/en-us/news/us/massachusetts-will-give-you-a-2475-gift-card-if-you-get-vaccinated-or-boosted/ar-AA14H0pA

$75 gift card for getting vaccinated against COVID-19,

through Dec. 31st

Adults and children alike,

first dose, second dose, or booster shots.

Boston Public Health Commission.

https://support.google.com/youtube/answer/11161123

Vaccine safety: content alleging that vaccines cause chronic side effects,

outside of rare side effects that are recognized by health authorities

Efficacy of vaccines: content claiming that vaccines do not reduce transmission or contraction of disease

Ingredients in vaccines: content misrepresenting the substances contained in vaccines

Endemic common human coronaviruses

About 20% of colds

https://covid19.nj.gov/faqs/coronavirus-information/about-the-virus/how-are-the-coronaviruses-that-cause-the-common-cold-different-from-the-covid-19-virus

https://www.cdc.gov/coronavirus/general-information.html

Types 229E, NL63, OC43, and HKU1

usually cause mild to moderate upper-respiratory tract illnesses,

like the common cold.

runny nose
sore throat
headache
fever
cough

general feeling of being unwell

Human coronaviruses can sometimes cause lower-respiratory tract illnesses,

such as pneumonia or bronchitis.

This is more common in people with cardiopulmonary disease,

weakened immune systems, infants, and older adults.

Cross-reactive memory T cells associate with protection against SARS-CoV-2 infection in COVID-19 contacts

https://www.nature.com/articles/s41467-021-27674-x

https://www.webmd.com/lung/news/20220111/common-cold-covid-protection

Cross-reactive immune responses

Common cold coronaviruses and SARS-CoV-2

The frequency of baseline cross-reactive T cells,

is correlated with the infection outcome following SARS-CoV-2 exposure,

and we observe significantly higher frequencies of cross-reactive memory T cell responses in PCR-negative contacts.

Here we assess 52 COVID-19 household contacts

Studied peripheral blood mononuclear cells

(Lymphocytes as opposed to neutrophils)

T cells specific for spike, nucleocapsid, membrane, envelope and ORF1 SARS-CoV-2 epitopes,

(Open Reading Frame, about a tenth of the viral genome)

These T cells cross-react with human endemic coronaviruses.

We observe higher frequencies of cross-reactivity

Memory T cells cross reacted with nucleocapsid-specific antigens significantly

Memory T cells did not seem to cross react with pre-existing spike-cross-reactive T cells

Our results are thus consistent with pre-existing non-spike cross-reactive memory T cells protecting SARS-CoV-2-naïve contacts from infection,

thereby supporting the inclusion of non-spike antigens in second-generation vaccines.

China

66% per cent of over-80s are double vaccinated

68% per cent of over-60s have been boosted

1.3 to 2.1 million lives at risk

https://www.telegraph.co.uk/global-health/science-and-disease/germany-urges-china-end-lockdowns-western-vaccines/?WT.mc_id=e_DM71323&WT.tsrc=email&etype=Edi_GHS_New_Tue_B&utmsource=email&utm_medium=Edi_GHS_New_Tue_B20221129&utm_campaign=DM71323

https://www.medscape.com/viewarticle/984612?src=wnl_edit_tpal&uac=127834AR&impID=4926650&faf=1

November up to 26th

Cases 31,709 + 35,183 + 39,791

(only a few imported cases)

Of the 39,791 cases

3,709 were symptomatic

36,082 were asymptomatic

(National Health Commission)

Deaths, + 1 = 5,233